Chemoimmunotherapy with rituximab, cyclophosphamide and prednisolone in IgM paraproteinaemic neuropathy: evidence of sustained improvement in electrophysiological, serological and functional outcomes.

Haematologica · 2021 · PMC7776249 · PMID 32354875

Europe PMC DOI

hedged sentence

0.2600

closest p · 5.2× alpha

0.2600

boldest claim

The sentences

showed a trendP =0.26not close (p > 0.1)

Sensory nerve action potential (SNAP) sum score also showed a trend to improvement, increasing from 11.7 microvolts (uv) to 15.7 uv at 2 years, ( P =0.26) ( Figure 2B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.